Summary
The monoclonal antibody ONS-M21 recognizes an antigen found on the surface of glioma and medulloblastoma cells but does not react with the antigens of normal brain tissue. We purified and identified the 140-kDa protein by means of an antibody-binding affinity column. This 140-kDa antigen has sequences homologous to the amino-terminal region and five parts of the internal domain of integrin α3. When the integrin α3-related sequences was amplified and used to analyse the mRNA of glioma and medulloblastoma surgical specimens, the transcription level of integrin α3 mRNA appeared to be quantitatively correlated with the grade of malignancy. These findings suggest that the ONS-M21 antibody, which reacts with integrin α3, might be useful in the diagnosis of gliomas and medulloblastomas.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Boku, N., Yoshida, S., Ohtsu, A., Fujii, T., Koba, I., Oda, Y., Ryu, M., Matsumoto, T., Hasebe, T., Hosokawa, K., Yama, T., Saito, D., Moriya, N. & Abe, K. (1995). Expression of integrin α3 in gastric and colorectal cancers: Its relation to wall construction and mode of invasion. Jpn J Cancer Res 86: 934–940.
Daghighian, F., Pentlow, K. S., Larson, S. M., Graham, M. C., DiResta, G. R., Yeh, S. D. J., Macapinlac, H., Finn, R. D., Arbit, E. & Cheung, N. K. V. (1993). Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumor with applications to microdosimetry: Positron emission tomography studies of iodine-124 labeled 3F8 monoclonal antibody in glioma. Eur J Nucl Med 20: 402–409.
Dan, M. D., Schlachta, C. M., Guy, J., McKenzie, R. G., Dorsscheid, D. R., Sandor, V. A., Villemure, J. G. & Price, G. B. (1992). Human antiglioma monoclonal antibodies from patients with astrocytic tumors. J Neurosurg 76: 660–669.
Dan, M. D., Earley, E. M., Griffin, M. C., Maiti, P. K., Prashar, A. K., Yuan, X. Y., Friesen, A. D. & Kaplan, H. A. (1995). Human monoclonal antibody BT32/A6 and a cell cycle-independent glioma-associated surface antigen. J Neurosurg 82: 475–480.
Dastidar, S. G. & Sharma, S. K. (1995). Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular weight 38 kDa and inhibits tumor growth in nude mice. J Neuroimmunol 56: 91–98.
Daumas-Duport, C., Scheithauer, B., O’Fallon, J. & Kelly, P. (1988). Grading of astrocytoma. A simple and reproducible method. Cancer 62: 2152–2165.
Elices, M. J., Urry, L. A. & Hemler, M. E. (1991). Receptor function for the integrin VLA-3: Fibronectin, collagen, and laminin binding are differentially influenced by ARG-GLY-ASP peptide and by divalent cations. J Cell Biol 112: 168–181.
Evans, A. E., Jenkin, R. D., Sposo, R., Ortega, J. A., Wilson, C. B., Wara, W., Ertel, I. J., Kramer, S., Chang, C. H., Leikin, S. L. & Hammond, G. D. (1990). The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and predonisone. J Neurosurg 72: 572–582.
Faillot, T., Magdelent, H., Mady, E., Stasiecki, P., Fohanno, D., Gropp, P., Poisson, M. & Delattre, J. Y. (1996). A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas. Neurosurgery 39: 478–483.
Fradet, Y., Cardo, C. C., Thomson, T., Daly, M. E., Whitmore, W. F., Jr, Lloyd, K. O., Melamed, M. R. & Old, L. J. (1984). Cell surface antigen of human bladder cancer defined by mouse monoclonal antibody. Proc Natl Acad Sci USA 81: 224–228.
Honore, B., Madsen, P., Rasmussen, H. H., Vandekerckhove, J., Celis, J. E. & Leffers, H. (1993). Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human pre-mRNA splicing factor SF2. Gene 134: 283–287.
Jaskiewicz, K. & Chasen, M. R. (1995). Differential expression of transforming growth factor alpha, adhesion molecules and integrin in primary, metastatic liver tumors and in cirrhosis. Anticancer Res 15: 559–562.
Kleihues, P. & Burger, P. C. (1993). Histological Typing of Tumors of the Central Nervous System, Springer: Berlin
McGeer, P. L., Zhu, S. G. & Dedhar, S. (1990). Immunostaining of human brain capillaries to antibodies to very late antigens. J Neuroimmunol 26: 213–218.
Moriuchi, S., Shimizu, K., Miyao, Y. & Hayakawa, T. (1993). Characterization of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas. Br J Cancer 68: 831–837.
Ohtomo, T., Tsuchiya, M., Sayo, K., Shimizu, K., Moriuchi, S., Miyao, Y., Akimoto, T., Akamatsu, K., Hayakawa, T. & Ohsugi, Y. (1995). Humanization of mouse ONS-M21 antibody with the aid of hybrid variable regions. Mol Immunol 32: 406–407.
Okada, H., Yoshida, J., Seo, H., Wakabayashi, T., Sugita, K. & Hagiwara, M. (1994). Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes overexpressed CD44 in glioma cells. Cancer Immunol Immunother 39: 313–317.
Paulus, W., Baur, I., Schuppan, D. & Roggendorf, W. (1993). Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143: 154–163.
Romeijin, P., Lenthall, R., Stavrou, D., Melcher, D., Ladyman, H. & Ritter, M. A. (1994). Identification of glioma-associated antigen MUC 2–63 as CD44. Br J Cancer 70: 799–803.
Schold, S. C., Zalutsky, M. R., Coleman, R. E., Glantz, M. J., Friedman, A. H., Jaszczak, R. J., Bigner, S. H. & Bigner, D. D. (1993). Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma. Invest Radiol 28: 488–496.
Schrappe, M., Bumol, T. F., Apelgren, L. D., Briggs, S. L., Koppel, G. A., Markowittz, D. D., Mueller, B. M. & Reisfeld, R. A. (1992). Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine- 3-carboxyhydrazide and monoclonal antibody 9.2.27. Cancer Res 52: 3838–3844.
Shimizu, K., Park, K. C., Tamura, K., Kishima, H., Kawata, H., Yoshimura, Y., Sekimori, Y., Miyao, Y. & Hayakawa, T. (1998). Internalization with high targeting potential of mouse monoclonal antibody ONS-M21 recognizing human malignant glioma antigen. Cancer Lett 27: 171–176.
Shiramarao, P., Steffner, P. & Gehlsen, K. R. (1993). Biochemical evidence for a homophilic interaction of the α3β1 integrin. J Biol Chem 268: 22036–22041.
Suzuki, H., Shibata, H., Murakami, M., Sato, A., Naito, M., Ichihara, A., Matsumoto, A., Tsujimoto, G., Hiarasawa, A., Horie, K. & Saruta, T. (1995). Modulation of angiotensin II type 1 receptor mRNA expression in human blood cells: Comparison of platelets and mononuclear leucocytes. Endo J 42: 15–22.
Takada, Y., Murphy, E., Pil, P., Chen, C., Ginsberg, M. H. & Hemler, M. E. (1991). Molecular cloning and expression of the cDNA for α3 subunit of human α3β1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J Cell Biol 115: 257–266.
Tamura, K., Shimizu, K., Yamada, M., Okamoto, Y., Matsui, Y., Park, K. C., Mabuchi, E., Moriuchi, S. & Mogami, H. (1989). Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation. Cancer Res 49: 5380–5384.
Tsuji, T., Hakomori, S. I. & Osawa, T. (1991). Identification of human galactoprotein b3, an oncogenic transformation-induced membrane glycoprotein, as VLA- 3 α subunit: the primary structure of human integrin α3. J Biochem 109: 659–665.
Weitzman, J. B., Chen, A. & Hemler, M. E. (1995). Investigation of the role of integrins in cell–cell adhesion. J Cell Sci 108: 3635–3644.
Weitzman, J. B., Hemler, M. E. & Brodt, P. (1996). Reduction of tumorigenicity by α3 integrin in a rhabdomyosarcoma cell line. Cell Adh Comm 4: 41–52.
Williams, J. A., Wessels, B. W., Edwards, J. A., Kopher, K. A., Wanek, P. W., Whram, M. D., Order, S. E. & Klein, J. L. (1990). Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies. Cancer Res 50: 974–979.
Zhao, J., Nobuhito, A. & Nishimoto, S. K. (1995). Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control. Gene 155: 159–165.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kishima, H., Shimizu, K., Tamura, K. et al. Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas. Br J Cancer 79, 333–339 (1999). https://doi.org/10.1038/sj.bjc.6690053
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690053
Keywords
This article is cited by
-
Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma
Clinical & Experimental Metastasis (2007)
-
Transforming Growth Factor-β1 Upregulates Transcription of α3 Integrin Gene in Hepatocellular Carcinoma Cells Via Ets-transcription Factor-binding Motif in the Promoter Region
Clinical & Experimental Metastasis (2005)
-
Physiological and Pathological Roles of α3β1 Integrin
Journal of Membrane Biology (2004)